Contineum Therapeutics’ M1 receptor antagonist has failed to move the needle in a phase 2 vision test for patients with a common form of multiple sclerosis. The Johnson & Johnson-partnered asset, ...

An MS-13 member testified on Tuesday he and others were following orders from two of the deadly gang’s national leaders when they hacked a member of the Sailors clique to death with machetes, beheaded ...

It's a new dawn for MSNBC, which is being rebranded and will now be known as MS NOW. The transition comes as the channel breaks off from its current parent company, Comcast NBCUniversal, and moves to ...

As momentum for Biogen’s newer drugs for neurological disorders builds at a slow and steady pace, it appears that the company can still count on its older products to hold down the fort and support ...

Academics at Princeton University, the University of Wisconsin-Madison, as well as different universities in New Jersey and an artificial intelligence hub in the state are planning to use a new kind ...

Obexelimab, a therapy Zenas Biopharma is developing for a range of autoimmune diseases, almost completely prevented the formation of new inflammatory lesions in adults with relapsing forms of multiple ...

Microsoft has released out-of-band (OOB) security updates to patch a critical-severity Windows Server Update Service (WSUS) vulnerability with publicly available proof-of-concept exploit code. WSUS is ...

A biology teacher and mother-of-two has become the first UK patient to receive a "gamechanger" therapy to treat multiple sclerosis (MS). Emily Henders, 37, from Bushey, Hertfordshire, was treated at ...

The members of MS-13 joined the notorious gang for kinship and protection in an unfamiliar country — and getting into MS-13 isn’t all that different from getting hazed into a college fraternity, a ...

Ashok Gadi Parthi's 2025 Global Recognition Award celebrates his transformative contributions to data integration and cloud architecture. His innovative migration framework, cross-industry expertise, ...

Dublin, 7 October 2025 – Today, Microsoft is extending availability of Microsoft Dragon Copilot, an AI clinical assistant, to Ireland. Dragon Copilot brings together the trusted natural language voice ...

The MarketWatch News Department was not involved in the creation of this content. Live Demonstrations of AI Site Twin Technology to Highlight How Advanced AI is Transforming Clinical Trial Timelines ...